利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.033 秒)

    Treatment of inflammatory disorders
    1.
    发明申请
    Treatment of inflammatory disorders 审中-公开

    公开(公告)号：US20060276440A1

    公开(公告)日：2006-12-07

    申请号：US11325615

    申请日：2006-01-03

    申请人： Wenqian An ,  Jun Park ,  Mehran Khodadoust ,  Hans-Jurgen Hess ,  Md. Hussom

    发明人： Wenqian An ,  Jun Park ,  Mehran Khodadoust ,  Hans-Jurgen Hess ,  Md. Hussom

    IPC分类号： A61K31/57 ,  A61K31/517 ,  A61K31/428 ,  A61K31/366 ,  A61K31/203

    CPC分类号： A61K31/203 ,  A61K31/05 ,  A61K31/09 ,  A61K31/165 ,  A61K31/19 ,  A61K31/343 ,  A61K31/365 ,  A61K31/366 ,  A61K31/37 ,  A61K31/415 ,  A61K31/428 ,  A61K31/498 ,  A61K31/517 ,  A61K31/56 ,  A61K31/57 ,  C07F9/12

    摘要： Methods of treating an inflammatory disorder include administering an effective amount of a compound represented by Structural Formula (I): Ring A is optionally substituted, contains zero, one, two, or three double bonds, and is optionally fused to an aliphatic, aryl or heteroaryl ring; X is an optionally substituted 1 to 3 carbon aliphatic chain that is optionally fused to a monocyclic, optionally substituted, aliphatic, heterocyclic, aryl, or heteroaryl ring, wherein one or two carbons in X are optionally replaced with —O—, —S—, or —NRe—; Y is carbon or nitrogen; R1 and R2 are independently —H, —OH, —CN, —NO2, —NRfRg, halogen, optionally substituted alkyl, or optionally substituted alkoxy; or R1 and R2 together link the carbons to which they are bonded with a bond, —O—, —S—, or —NRh—; R3 and R4 are independently —H, —OH, —CN, —NO2, —NRiRj, halogen, optionally substituted alkyl, or optionally substituted alkoxy, or R4 is ═O; or R3 and R4, taken together with the atoms to which they are bonded, form a monocyclic, optionally substituted, aliphatic, heterocyclic, aryl, or heteroaryl ring that is optionally fused to a monocyclic or bicyclic, optionally substituted, aliphatic, heterocyclic, aryl, or heteroaryl ring; Re-Rj are independently —H or optionally substituted alkyl; and each of the OSM signaling inhibitor compounds has at least one hydrogen atom bonded to an oxygen, nitrogen, or sulfur atom. The OSM signaling inhibitor compounds also include pharmaceutically acceptable salt or solvates of the compounds represented by Structural Formula (I).